Clinical Trial Update: Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients [Phase 1]

View source ↗

Summary

Phase 1 PET biodistribution study evaluating [11C]-GSK2256098 in healthy subjects and pulmonary arterial hypertension patients; completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• GSK2256098

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension, Pulmonary | Phase 1 | Status: COMPLETED | Results posted: 2018-08-17